Lilly Sells Keflex Antibiotic To Advancis; Plans For Once-Daily Dosing Underway
This article was originally published in The Pink Sheet Daily
Executive Summary
Advancis will commence clinical trials with Keflex using proprietary Pulsys drug delivery technology. The company also has Pulsys agreements with GSK for Augmentin and with Par for amoxicillin.
You may also be interested in...
Advancis Targeting Pharmacies In Effort To Energize Keflex 750 Sales
In sit-downs with retail pharmacy chains, Advancis is offering price incentives and arguing that the new cephalexin strength needs to be stocked because it has no generic equivalent.
Advancis Targeting Pharmacies In Effort To Energize Keflex 750 Sales
In sit-downs with retail pharmacy chains, Advancis is offering price incentives and arguing that the new cephalexin strength needs to be stocked because it has no generic equivalent.
Advancis Will Go It Alone On Amoxicillin Pulsys
Firm will file NDA for pulsatile amoxicillin formulation in late 2006/early 2007 following positive Phase III results.